High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.
CD4-positive T-lymphocytes
CD45-positive leukocytes
CD8-positive T-lymphocytes
NanoString
immunohistochemistry
leukocyte common antigens
ovarian neoplasms
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Sep 2023
05 Sep 2023
Historique:
received:
31
07
2023
revised:
26
08
2023
accepted:
03
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Cancer-related immunity plays a significant role in the outcome of ovarian cancer, but the exact mechanisms are not fully explored. A retrospective, real-life observational study was conducted including 57 advanced ovarian cancer patients. Immunohistochemistry for CD4
Identifiants
pubmed: 37761986
pii: ijms241813684
doi: 10.3390/ijms241813684
pmc: PMC10530512
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Research and Innovation Fund
ID : NVKP_16-1-2016-0004
Organisme : Semmelweis University
ID : APC coverage
Références
Int Immunopharmacol. 2017 Nov;52:7-14
pubmed: 28846888
Genome Biol. 2014;15(12):550
pubmed: 25516281
Gynecol Oncol. 2020 Nov;159(2):554-562
pubmed: 32951896
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
pubmed: 16344461
JAMA Oncol. 2017 Dec 1;3(12):e173290
pubmed: 29049607
BMC Womens Health. 2023 Jun 3;23(1):298
pubmed: 37270486
Dtsch Arztebl Int. 2011 Sep;108(38):635-41
pubmed: 22025930
J Int Med Res. 2021 Dec;49(12):3000605211066245
pubmed: 34939862
Biomed Pharmacother. 2020 Dec;132:110873
pubmed: 33068926
Ann Oncol. 2015 Feb;26(2):259-71
pubmed: 25214542
Gynecol Oncol. 2008 May;109(2):215-9
pubmed: 18314181
Gynecol Oncol. 2023 Jan;168:23-31
pubmed: 36368129
Mol Cancer Res. 2018 May;16(5):813-824
pubmed: 29523763
J Pathol. 2021 Nov;255(3):285-295
pubmed: 34322886
J Natl Cancer Inst. 2021 Aug 2;113(8):1005-1016
pubmed: 33523233
Cancer Treat Rev. 2012 Aug;38(5):451-66
pubmed: 21945823
Gynecol Oncol. 2018 Oct;151(1):10-17
pubmed: 30078505
N Engl J Med. 2003 Jan 16;348(3):203-13
pubmed: 12529460
Cancer Manag Res. 2019 Nov 12;11:9571-9583
pubmed: 31814759
Brief Bioinform. 2021 May 20;22(3):
pubmed: 32789507
Cell Physiol Biochem. 2017;41(2):475-483
pubmed: 28214872
Geroscience. 2023 Jun;45(3):1889-1898
pubmed: 36856946
Science. 2013 Jan 18;339(6117):286-91
pubmed: 23329041
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ginekol Pol. 2021;92(5):344-351
pubmed: 33914317
PLoS One. 2013 Nov 14;8(11):e80063
pubmed: 24244610
Cancer Immunol Res. 2022 Nov 2;10(11):1326-1339
pubmed: 36095166
Semin Oncol Nurs. 2019 Apr;35(2):151-156
pubmed: 30867104
Biosci Rep. 2020 Oct 30;40(10):
pubmed: 33043974
Br J Cancer. 2020 Jun;122(12):1803-1810
pubmed: 32249277
Cancers (Basel). 2021 Jul 30;13(15):
pubmed: 34359755
Front Immunol. 2022 Oct 28;13:1018962
pubmed: 36389779
Cancers (Basel). 2020 Dec 18;12(12):
pubmed: 33352957
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Cell Rep Med. 2022 Dec 20;3(12):100856
pubmed: 36543113
Gynecol Oncol. 2016 Oct;143(1):120-127
pubmed: 27470997
J Ovarian Res. 2020 Jun 8;13(1):65
pubmed: 32513298
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Clin Cancer Res. 2020 Dec 1;26(23):6362-6373
pubmed: 32928797
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Oncotarget. 2017 Feb 28;8(9):15621-15631
pubmed: 28152503
Immunol Invest. 2016 Nov;45(8):712-720
pubmed: 27420920
Eur J Obstet Gynecol Reprod Biol. 2017 Aug;215:55-61
pubmed: 28601728
Clin Dev Immunol. 2010;2010:791603
pubmed: 21318181
Front Immunol. 2023 Mar 13;14:1022942
pubmed: 36993949
Indian J Anaesth. 2011 Mar;55(2):111-5
pubmed: 21712864
Front Immunol. 2022 Aug 08;13:943389
pubmed: 36003381
Front Immunol. 2022 Sep 05;13:965331
pubmed: 36131935
Front Genet. 2022 Sep 09;13:886170
pubmed: 36159999
Cancer Med. 2021 Jun;10(12):3905-3918
pubmed: 33955198
Cancer Gene Ther. 2015 Mar;22(4):198-206
pubmed: 25721210
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188361
pubmed: 32234508
Cancer Med. 2021 May;10(9):3045-3058
pubmed: 33811746
Vaccines (Basel). 2021 Aug 12;9(8):
pubmed: 34452019
Mol Omics. 2018 Oct 8;14(5):341-351
pubmed: 30129640
PLoS One. 2009 Jul 29;4(7):e6412
pubmed: 19641607
Front Immunol. 2022 Jun 24;13:872991
pubmed: 35812434
Front Immunol. 2022 Aug 10;13:956224
pubmed: 36032075
Gynecol Oncol. 2010 Mar;116(3):556-62
pubmed: 20006900
Cancer Immunol Immunother. 2021 Oct;70(10):2951-2960
pubmed: 33713153